There is growing evidence suggesting a dysfunctional interaction between M2-like TAMs and exhausted CD8+ T cells and/or the lack of progenitor exhausted CD8+ T cells in advanced and metastatic ccRCC might play a major role in resistance to available immune checkpoint therapies. Here, CD8A is linked to nonpapillary renal cell carcinoma.